Recombinant Vaccines Market To Surpass US $1.3 Bn Threshold By 2025, With North America Positioned As Growth Engine

Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease. These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue.

Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms. There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population. According to Global Agriculture report, there were around 315 million tons of meat produced worldwide in 2014 and expected to increase to 318.8 million tons in 2015.

Get a sample pages of this report@: https://www.coherentmarketinsights.com/insight/request-sample/455 

Market Dynamics

The recent past has witnessed a steady rise in incidence of zoonotic and infectious diseases in humans and animals as well, which lead to the increased research & developments for the innovation of new and effective recombinant vaccines for the prevention of diseases. Government has also taken an initiative to increase awareness regarding vaccination to prevent diseases in community. Manufacturing companies have also started some beneficial programs to provide vaccination free of cost to poor people, which creates a highly conducive environment for growth of the recombinant vaccines market in near future.

National Immunization Program by Queensland Government in Australia and Indradhanush vaccination program in India works to provide vaccination among children throughout the nation. Various organizations such as World Health Organization, World Bank, and United Nations Children’s Funds has also taken and initiative to increase vaccination.

Need a discount?

Note: *The discount is offered on the Standard Price of the report.

Get Your Copy at a Discounted Rate!!! Limited Time Offer!!! @ https://www.coherentmarketinsights.com/insight/request-discount/455   

Detailed Segmentation

Global Recombinant Vaccines Market, By Product Type
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Global Recombinant Vaccines Market, By Disease Type
Infectious Disease
Cancer
Allergy
Others
Global Recombinant Vaccines Market, End User
Recombinant Human Vaccines
Animal Recombinant Vaccines
Poultry
Companion Animal Vaccines
Livestock
Porcine
Aquaculture Vaccines

Some major key players in the recombinant vaccines market include Merck & Co. Inc., Novartis AG, Protein Science Corporation, GlaxoSmithKline Plc., Green Cross Corporation, Bayer AG, Sanofi S A, Pfizer Inc., and Bharat Biotech.

Contact us for any query or to get a personalized report@: https://www.coherentmarketinsights.com/insight/request-customization/455

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.